Blog

In Brief This Week: Calibre Scientific, Deep Genomics, Kiyatec, and More

Empirico Inks Drug Target Discovery Alliance With Antisense Drug Firm Ionis

A class of antibiotics could be potential treatment for frontotemporal dementia

Researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.

New framework developed to estimate the growth of individual cancer

Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.

Study sheds new light on impact of common plasticizer on human reproductive health

Researchers at Harvard Medical School and the New York State Department of Health have discovered how a common plasticizer associated with human reproductive abnormalities likely does its damage at the molecular level.

Interactive single cell RNA-Seq analysis with Single Cell Toolkit (SCTK)

Researchers from Boston University School of Medicine present the Single Cell Toolkit (SCTK), an R package and interactive single cell RNA-sequencing (scRNA-Seq) analysis package that provides the first complete workflow for scRNA-Seq data analysis...

Transcriptome Analysis: Stretching Toward Longer Reads

The transcriptome—all the RNA expressed within a cell—is a valuable snapshot in time that reveals which genes a cell is actively expressing. Transcriptome analysis helps researchers to...

Global profiling of long noncoding RNAs in Cerebral Cavernous Malformations using transcriptome-wide approach

Cerebral cavernous malformations (CCMs) are low-flow vascular malformations in the brain associated with recurrent hemorrhage and seizures. Despite accumulating evidence demonstrating the role of lncRNAs in cerebrovascular disorders, their identification in CCMs pathology remains unknown. The objective of this study was to identify lncRNAs associated with CCMs pathogenesis using CCM patient cohorts. For the first ...